Biomind Labs Inc. (BMND.NE)

0.2300 -0.1750 (-43.21%) At close: 10:05AM EDT

Biomind Labs Inc.

Building Ceibo Of. 002
Camino Saravia s/n 91.000, Pando
Canelones
Uruguay

https://www.biomindlabs.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 5

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Alejandro Antalich	CEO & Director	94.56k	N/A	1974
Mr. Oscar Alejandro Leon	CFO & Director	N/A	N/A	1960
Ms. Paola Diaz Dellavalle Ph.D.	Chief Scientific Officer	N/A	N/A	N/A
Mr. Juan Presa	Chief Legal Officer	N/A	N/A	N/A
Ms. Magdalena Alvarez M.A.	Head of Communication	N/A	N/A	N/A
Mr. Martin Daners	Head of Quality Assurance & Regulatory Affairs	N/A	N/A	N/A

Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; and BMND08, a 5-Methoxy-N,N-dimethyltryptamine based candidate that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's-type cognitive impairment. It is also developing new and preclinical drug candidates, including BMND02 for treating fibromyalgia, BMND03 for treating addictive disorders, BMND05 for treating chronic pain, BMND06 for treating inflammatory disorders, and BMND07 for treating major depressive disorder. The company is headquartered in Canelones, Uruguay.

Corporate governance

Biomind Labs Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.